SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!
LGND 188.97-0.6%Dec 31 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Sleepman who wrote (29295)9/21/1999 5:28:00 PM
From: Henry Niman  Read Replies (1) of 32384
 
Yes:

Lisle M. Nabell, Principal Investigator, Ph: 205-934-3061
University of Alabama Comprehensive Cancer Center
Birmingham, Alabama, USA

Charles W. Taylor, Principal Investigator, Ph: 520-626-2266
Arizona Cancer Center
Tucson, Arizona, USA

Laura Fulper Hutchins, Principal Investigator, Ph: 501-686-5222
University of Arkansas for Medical Sciences
Little Rock, Arkansas, USA

Przemyslaw Twardowski, Principal Investigator, Ph: 626-359-8111ext 2867
Beckman Research Institute, City of Hope
Duarte, California, USA

Debashish Tripathy, Principal Investigator, Ph: 415-3537618
Breast Care Center UCSF
San Francisco, California, USA

John A. Glaspy, Principal Investigator, Ph: 310-794-1274
Jonsson Comprehensive Cancer Center, UCLA
Los Angeles, California, USA

Christy Ann Russell, Principal Investigator, Ph: 323-865-3900
USC/Norris Comprehensive Cancer Center
Los Angeles, California, USA

Barbara A. Burtness, Principal Investigator, Ph: 203-785-6007
Yale Comprehensive Cancer Center
New Haven, Connecticut, USA

Said M. Baidas, Principal Investigator, Ph: 202-687-2198
Vincent T. Lombardi Cancer Research Center, Georgetown University
Washington, District of Columbia, USA

Neil Abramson, Principal Investigator, Ph: 904-202-7048
Baptist Regional Cancer Institute - Jacksonville
Jacksonville, Florida, USA

Edith A. Perez, Principal Investigator, Ph: 904-953-7283
Mayo Clinic Jacksonville
Jacksonville, Florida, USA

Charles L. Vogel, Principal Investigator, Ph: 305-674-3030
Sylvester Cancer Center, University of Miami
Miami, Florida, USA

Brian F. Issell, Principal Investigator, Ph: 808-586-3013
Cancer Research Center of Hawaii
Honolulu, Hawaii, USA

William John Gradishar, Principal Investigator, Ph: 312-908-9412
Robert H. Lurie Comprehensive Cancer Center, Northwestern University
Chicago, Illinois, USA

Chris Theodossiou, Principal Investigator, Ph: 504-568-5847
Louisiana State University School of Medicine
New Orleans, Louisiana, USA

Steven E. Come, Principal Investigator, Ph: 617-667-4599
Beth Israel Deaconess Medical Center
Boston, Massachusetts, USA

George Daniel Demetri, Principal Investigator, Ph: 617-632-3985
Dana-Farber Cancer Institute
Boston, Massachusetts, USA

Nikolay V. Dimitrov, Principal Investigator, Ph: 517-353-4677
Michigan State University
East Lansing, Michigan, USA

Tanya L. Repka, Principal Investigator, Ph: 612-624-0123
University of Minnesota
Minneapolis, Minnesota, USA

Stefano R. Tarantolo, Principal Investigator, Ph: 402-559-6210
University of Nebraska Medical Center
Omaha, Nebraska, USA

Clifford A. Hudis, Principal Investigator, Ph: 212-639-6483
Memorial Sloan-Kettering Cancer Center
New York, New York, USA

Victoria Seewaldt, Principal Investigator, Ph: 614-293-6452
Arthur G. James Cancer Hospital - Ohio State University
Columbus, Ohio, USA

Leslie Rodgers Laufman, Principal Investigator, Ph: 614-846-0044
Hematology Oncology Consultants Inc
Columbus, Ohio, USA

Richard S. Bornstein, Principal Investigator, Ph: 216-595-2599
Mt. Sinai Center for Breast Health
Beachwood, Ohio, USA

Jose Leis, Principal Investigator, Ph: 503-494-1551
Oregon Health Sciences University
Portland, Oregon, USA

Angela DeMichele, Principal Investigator, Ph: 215-614-1850
University of Pennsylvania Cancer Center
Philadelphia, Pennsylvania, USA

Francisco J. Esteva, Principal Investigator, Ph: 713-792-2817
University of Texas - MD Anderson Cancer Center
Houston, Texas, USA

Peter Marcus Ravdin, Principal Investigator, Ph: 210-567-4777
University of Texas Health Science Center at San Antonio
San Antonio, Texas, USA

Roger B. Cohen, Principal Investigator, Ph: 804-243-6356
Cancer Center, University of Virginia HSC
Charlottesville, Virginia, USA
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext